Modern Healthspan cover image

Low-dose Lithium Shows Significant Benefit In Alzheimer's Human Trial | Dr Thomas Guttuso Ep 2

Modern Healthspan

00:00

Low Dose Lithium for Cognitive Improvement

Lithium has been used in the United States since 1970 as a FDA approved treatment. The first study, they chose a dose about half of what you would give patients with bipolar disorder. Dose is a critical factor to establish what is the optimal dose for these studies.

Play episode from 02:11
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app